EDGAR·FLOW

JUPITER NEUROSCIENCES, INC. — Form 10-Q

Filed November 16, 2026 · analyzed by the Periodic Agent
10-Q ▼ Likely negative significance 72/100
What the filing says
Jupiter Neurosciences agreed with YA II PN, Ltd. (Yorkville Advisors) to extend payment of $217,938 outstanding on a convertible note installment originally due October 1, 2026, to December 16, 2026, plus a $21,793.80 extension fee (10% of outstanding balance). If unpaid by December 16, the company must file a post-effective amendment to register additional shares by January 2, 2027, with a final payment deadline of January 31, 2027.
Why this rating

Extension signals cash stress; $240k debt is 1.2% of $20M market cap but signals liquidity pressure and dilution risk via equity registration requirement.

Tradability signal
NO TRADE

No trade: only ~$20k traded in the last 30 min — too illiquid to enter and exit. (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it negative)
before filing · preread
$1.70 ▲ 0.00%
at our read · unknown
$1.70
+10 min · unknown
$1.65 ▼ 2.94%
+30 min · unknown
$1.55 ▼ 8.82%
+1 hr · unknown
$1.56 ▼ 8.24%
+4 hrs · unknown
$1.54 ▼ 9.41%

The stock had already moved +0.00% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ JUNS · stock on Yahoo Finance ↗

See more from November 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.